What biomedical equipment services does BiomedRx provide?

We provide preventive maintenance, corrective repair, calibration, electrical safety inspection, and isolated power system (IPS) testing for hospitals, surgery centers, and clinics.

Are your biomedical technicians certified?

Yes. Our BMETs are certified and our work follows Joint Commission, CMS, and NFPA 99 standards so your facility stays survey-ready.

How fast can you respond to an equipment failure?

We offer scheduled preventive maintenance plus priority on-call service to minimize downtime on critical medical equipment.

Do you help with regulatory compliance and documentation?

We do. Every service includes the documentation you need for Joint Commission, CMS, and NFPA 99 surveys.

How do I request service or a quote?

Call (424) 204-2382 or email info@biomedrx.com and our team will schedule an assessment.

BiomedRx | Medical Equipment Repair, Maintenance & Field Service

Medical equipment, always operational.

BiomedRx is a healthcare technology management company headquartered in Los Angeles. We repair, calibrate, and preventively maintain every modality of diagnostic and therapeutic medical equipment — and we test the isolated power systems that keep your ORs running.

Educational

FDA + CMS RAPID Pathway: What Biomed Departments Should Expect From Faster Breakthrough-Device Coverage

For years the gap between FDA market authorization and a Medicare national or local coverage determination has meant that a device could be legally marketed long before hospitals had a reliable reimbursement path for it. Efforts to close that gap build directly on the FDA's Breakthrough Devices Program and on CMS coverage frameworks such as Transitional Coverage for Emerging Technologies (TCET), both of which are aimed at moving designated devices through review and coverage decisions on a more predictable, parallel timeline rather than the traditional sequential one.

For a Healthcare Technology Management (HTM) department, faster coverage does not simply mean equipment arrives sooner — it compresses the window you have to complete incoming inspection, safety and electrical testing, network and cybersecurity vetting, and integration into the CMMS before the device is in clinical use. Departments should expect tighter on-boarding cycles, more emphasis on coverage-with-evidence-development style data capture, and closer coordination with supply chain, clinical engineering, and revenue-cycle teams so that a device authorized under a breakthrough designation is fully commissioned and documented before its first billed procedure.

Practically, this is a documentation and readiness story. Surveyors from The Joint Commission and CMS continue to expect that every device in service has a complete equipment history, a documented risk-based maintenance strategy, and evidence of staff training. Build your acceptance-testing checklist and your alternative-equipment-maintenance justification now, so that a newly covered breakthrough device does not enter the patient-care environment ahead of the records that prove it is safe and properly maintained.

Sources: FDA Breakthrough Devices Program; CMS TCET; The Joint Commission

May 6, 20269 min readBy BiomedRx Editorial

Informative

NFPA 99 (2026 Edition): Tighter Category 1 Verification Intervals, New Wet-Location Documentation

NFPA 99, Health Care Facilities Code, is the backbone document behind how hospitals classify and maintain medical gas and vacuum systems, electrical distribution, and other risk-based building systems. Its Category 1 through Category 4 framework ties the rigor of testing and maintenance to the clinical consequence of failure — a Category 1 system is one whose failure is likely to cause major injury or death, which is why piped medical gas and isolated power in wet procedure locations receive the most scrutiny.

Whenever a new edition tightens verification intervals or adds documentation requirements, the real work lands on hospital electricians, facilities engineers, and biomeds who have to translate code language into concrete preventive-maintenance tasks and CMMS records. For piped gas systems that means confirming source alarms, zone valves, and outlet performance on schedule; for isolated power panels in wet procedure locations it means line isolation monitor (LIM) testing and a clear accountability trail showing who verified each panel and when.

The practical takeaway is to reconcile your PM program against the exact edition your Authority Having Jurisdiction has adopted, since CMS and accreditors survey to a specific adopted edition rather than to the newest one automatically. Confirm the applicable edition, update task frequencies and checklists accordingly, and keep completed test records retrievable — that documentation is what a surveyor will actually ask to see.

Sources: NFPA 99; CMS; The Joint Commission

May 14, 20265 min read

Field Notes

Dispatch: Why That Crash-Cart Defibrillator Was Failing Self-Test Every Other Tuesday

Three Westside hospitals, three identical crash-cart defibrillators, one maddeningly consistent failure pattern: a self-test fault that appeared roughly every other Tuesday. Our first instinct was the same as everyone's — the battery pack. Defibrillator batteries are a genuine reliability concern, and manufacturers and safety bodies emphasize that a unit only helps in a code if its automated self-test is passing and its battery is charged. But swapping packs didn't stop the faults, so we widened the investigation.

The breakthrough came from correlating the failure timestamps with something outside the device entirely: the environmental-services floor-care schedule. On those Tuesday nights the units were being rolled to the same alcove near a housekeeping closet, exposed to temperature and humidity swings and, in one case, left plugged into a receptacle that shared a circuit that cycled. The self-test wasn't lying — it was reporting a real environmental stress the device kept encountering on a weekly cadence.

The fix was procedural rather than technical: standardize where crash carts are staged, keep defibrillators within their rated operating environment, and verify each unit's self-test indicator on every shift check. It is a reminder that not every recurring biomedical failure is a component defect — sometimes the equipment is fine and the workflow around it is the fault, which is exactly why incident investigation and manufacturer maintenance guidance both stress looking at use environment, not just the box.

Sources: FDA External Defibrillators; ECRI

May 21, 20264 min read

Built on uptime, accountability, and engineering

BiomedRx is a veteran-owned, minority-owned U.S. Government contractor and the flagship of the BiomedRx Service Network. We've conducted biomedical engineering and educational services across the United States and the Western Hemisphere — for community hospitals, federal health systems, medical device manufacturers, and emerging OEMs going through their first 510(k) submissions.

Our equipment management programs are designed to keep your equipment in peak operational readiness while reducing total cost of ownership. Our reports are surveyor-ready. Our techs are clinically aware. We answer the phone.